China Anti Obesity Drugs Market Research Report 2016

December 2016 | 114 pages | ID: CDAC79C8A5DEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Anti Obesity Drugs

Revenue, means the sales value of Anti Obesity Drugs

This report studies Anti Obesity Drugs in China market, focuses on the top players in China market, with capacity, production, price, revenue and market share for each manufacturer, covering

• Pfizer
• Merck
• Roche
• GlaxoSmithKline
• AstraZeneca
• Boehringer Ingelheim
• Novo Nordisk
• Eisai
• Norgine
• Arena Pharmaceuticals
• Orexigen Therapeutics
• Vivus
• Alizyme
• Rhythm Pharmaceuticals
• Shionogi
• Zafgan

Split by product Type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by Application, this report focuses on consumption, market share and growth rate of Anti Obesity Drugs in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

China Anti Obesity Drugs Market Research Report 2016

1 ANTI OBESITY DRUGS MARKET OVERVIEW

1.1 Product Overview and Scope of Anti Obesity Drugs
1.2 Anti Obesity Drugs Segment by Type
  1.2.1 China Production Market Share of Anti Obesity Drugs Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Applications of Anti Obesity Drugs
  1.3.1 Anti Obesity Drugs Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 China Market Size (Value) of Anti Obesity Drugs (2011-2021)
1.5 China Anti Obesity DrugsStatus and Outlook
1.6 Government Policies

2 CHINA ANTI OBESITY DRUGS MARKET COMPETITION BY MANUFACTURERS

2.1 China Anti Obesity Drugs Capacity, Production and Share by Manufacturers (2015 and 2016)
2.2 China Anti Obesity Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.3 China Anti Obesity Drugs Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Anti Obesity Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti Obesity Drugs Market Competitive Situation and Trends
  2.5.1 Anti Obesity Drugs Market Concentration Rate
  2.5.2 Anti Obesity Drugs Market Share of Top 3 and Top 5 Manufacturers

3 CHINA ANTI OBESITY DRUGS MANUFACTURERS PROFILES/ANALYSIS

3.1 Pfizer
  3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.1.2 Anti Obesity Drugs Product Type, Application and Specification
    3.1.2.1 Type I
    3.1.2.2 Type II
  3.1.3 Pfizer Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.1.4 Main Business/Business Overview
3.2 Merck
  3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.2.2 114 Product Type, Application and Specification
    3.2.2.1 Type I
    3.2.2.2 Type II
  3.2.3 Merck 114 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.2.4 Main Business/Business Overview
3.3 Roche
  3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.3.2 121 Product Type, Application and Specification
    3.3.2.1 Type I
    3.3.2.2 Type II
  3.3.3 Roche 121 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.3.4 Main Business/Business Overview
3.4 GlaxoSmithKline
  3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.4.2 Dec Product Type, Application and Specification
    3.4.2.1 Type I
    3.4.2.2 Type II
  3.4.3 GlaxoSmithKline Dec Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.4.4 Main Business/Business Overview
3.5 AstraZeneca
  3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.5.2 Product Type, Application and Specification
    3.5.2.1 Type I
    3.5.2.2 Type II
  3.5.3 AstraZeneca Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.5.4 Main Business/Business Overview
3.6 Boehringer Ingelheim
  3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.6.2 Million USD Product Type, Application and Specification
    3.6.2.1 Type I
    3.6.2.2 Type II
  3.6.3 Boehringer Ingelheim Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.6.4 Main Business/Business Overview
3.7 Novo Nordisk
  3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.7.2 Pharmaceuticals Product Type, Application and Specification
    3.7.2.1 Type I
    3.7.2.2 Type II
  3.7.3 Novo Nordisk Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.7.4 Main Business/Business Overview
3.8 Eisai
  3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.8.2 Product Type, Application and Specification
    3.8.2.1 Type I
    3.8.2.2 Type II
  3.8.3 Eisai Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.8.4 Main Business/Business Overview
3.9 Norgine
  3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.9.2 Product Type, Application and Specification
    3.9.2.1 Type I
    3.9.2.2 Type II
  3.9.3 Norgine Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.9.4 Main Business/Business Overview
3.10 Arena Pharmaceuticals
  3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
  3.10.2 Product Type, Application and Specification
    3.10.2.1 Type I
    3.10.2.2 Type II
  3.10.3 Arena Pharmaceuticals Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)
  3.10.4 Main Business/Business Overview
3.11 Orexigen Therapeutics
3.12 Vivus
3.13 Alizyme
3.14 Rhythm Pharmaceuticals
3.15 Shionogi
3.16 Zafgan

4 CHINA ANTI OBESITY DRUGS CAPACITY, PRODUCTION, REVENUE, CONSUMPTION, EXPORT AND IMPORT (2011-2016)

4.1 China Anti Obesity Drugs Capacity, Production and Growth (2011-2016)
4.2 China Anti Obesity Drugs Revenue and Growth (2011-2016)
4.3 China Anti Obesity Drugs Production, Consumption, Export and Import (2011-2016)

5 CHINA ANTI OBESITY DRUGS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 China Anti Obesity Drugs Production and Market Share by Type (2011-2016)
5.2 China Anti Obesity Drugs Revenue and Market Share by Type (2011-2016)
5.3 China Anti Obesity Drugs Price by Type (2011-2016)
5.4 China Anti Obesity Drugs Production Growth by Type (2011-2016)

6 CHINA ANTI OBESITY DRUGS MARKET ANALYSIS BY APPLICATION

6.1 China Anti Obesity Drugs Consumption and Market Share by Application (2011-2016)
6.2 China Anti Obesity Drugs Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Application
  6.3.2 Emerging Markets/Countries

7 ANTI OBESITY DRUGS MANUFACTURING COST ANALYSIS

7.1 Anti Obesity Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Anti Obesity Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Anti Obesity Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 CHINA ANTI OBESITY DRUGS MARKET FORECAST (2016-2021)

11.1 China Anti Obesity Drugs Capacity, Production, Revenue Forecast (2016-2021)
11.2 China Anti Obesity Drugs Production, Import, Export and Consumption Forecast (2016-2021)
11.3 China Anti Obesity Drugs Production Forecast by Type (2016-2021)
11.4 China Anti Obesity Drugs Consumption Forecast by Application (2016-2021)
11.5 Anti Obesity Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Disclosure Section
Research Methodology
Data Source
China Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti Obesity Drugs
Figure China Production Market Share of Anti Obesity Drugs by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Anti Obesity Drugs Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure China Anti Obesity Drugs Revenue (Million USD) and Growth Rate (2011-2021)
Table China Anti Obesity Drugs Capacity of Key Manufacturers (2015 and 2016)
Table China Anti Obesity Drugs Capacity Market Share of Key Manufacturers (2015 and 2016)
Figure China Anti Obesity Drugs Capacity of Key Manufacturers in 2015
Figure China Anti Obesity Drugs Capacity of Key Manufacturers in 2016
Table China Anti Obesity Drugs Production of Key Manufacturers (2015 and 2016)
Table China Anti Obesity Drugs Production Share by Manufacturers (2015 and 2016)
Figure 2015 Anti Obesity Drugs Production Share by Manufacturers
Figure 2016 Anti Obesity Drugs Production Share by Manufacturers
Table China Anti Obesity Drugs Revenue (Million USD) by Manufacturers (2015 and 2016)
Table China Anti Obesity Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 China Anti Obesity Drugs Revenue Share by Manufacturers
Table 2016 China Anti Obesity Drugs Revenue Share by Manufacturers
Table China Market Anti Obesity Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure China Market Anti Obesity Drugs Average Price of Key Manufacturers in 2015
Table Manufacturers Anti Obesity Drugs Manufacturing Base Distribution and Sales Area
Table Manufacturers Anti Obesity Drugs Product Type
Figure Anti Obesity Drugs Market Share of Top 3 Manufacturers
Figure Anti Obesity Drugs Market Share of Top 5 Manufacturers
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Anti Obesity Drugs Market Share (2011-2016)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Merck Anti Obesity Drugs Market Share (2011-2016)
Table Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Roche Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Roche Anti Obesity Drugs Market Share (2011-2016)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure GlaxoSmithKline Anti Obesity Drugs Market Share (2011-2016)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure AstraZeneca Anti Obesity Drugs Market Share (2011-2016)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Boehringer Ingelheim Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Boehringer Ingelheim Anti Obesity Drugs Market Share (2011-2016)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Novo Nordisk Anti Obesity Drugs Market Share (2011-2016)
Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eisai Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Eisai Anti Obesity Drugs Market Share (2011-2016)
Table Norgine Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Norgine Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Norgine Anti Obesity Drugs Market Share (2011-2016)
Table Arena Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Arena Pharmaceuticals Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Arena Pharmaceuticals Anti Obesity Drugs Market Share (2011-2016)
Table Orexigen Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Orexigen Therapeutics Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Orexigen Therapeutics Anti Obesity Drugs Market Share (2011-2016)
Table Vivus Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Vivus Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Vivus Anti Obesity Drugs Market Share (2011-2016)
Table Alizyme Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alizyme Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alizyme Anti Obesity Drugs Market Share (2011-2016)
Table Rhythm Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Rhythm Pharmaceuticals Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Rhythm Pharmaceuticals Anti Obesity Drugs Market Share (2011-2016)
Table Shionogi Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Shionogi Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Shionogi Anti Obesity Drugs Market Share (2011-2016)
Table Zafgan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Zafgan Anti Obesity Drugs Capacity, Production, Revenue, Price and Gross Margin (2011-2016)
Figure Zafgan Anti Obesity Drugs Market Share (2011-2016)
Figure China Anti Obesity Drugs Capacity, Production and Growth (2011-2016)
Figure China Anti Obesity Drugs Revenue (Million USD) and Growth (2011-2016)
Table China Anti Obesity Drugs Production, Consumption, Export and Import (2011-2016)
Table China Anti Obesity Drugs Production by Type (2011-2016)
Table China Anti Obesity Drugs Production Share by Type (2011-2016)
Figure Production Market Share of Anti Obesity Drugs by Type (2011-2016)
Figure 2015 Production Market Share of Anti Obesity Drugs by Type
Table China Anti Obesity Drugs Revenue by Type (2011-2016)
Table China Anti Obesity Drugs Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Anti Obesity Drugs by Type (2011-2016)
Figure 2015 Revenue Market Share of Anti Obesity Drugs by Type
Table China Anti Obesity Drugs Price by Type (2011-2016)
Figure China Anti Obesity Drugs Production Growth by Type (2011-2016)
Table China Anti Obesity Drugs Consumption by Application (2011-2016)
Table China Anti Obesity Drugs Consumption Market Share by Application (2011-2016)
Figure China Anti Obesity Drugs Consumption Market Share by Application in 2015
Table China Anti Obesity Drugs Consumption Growth Rate by Application (2011-2016)
Figure China Anti Obesity Drugs Consumption Growth Rate by Application (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Anti Obesity Drugs
Figure Manufacturing Process Analysis of Anti Obesity Drugs
Figure Anti Obesity Drugs Industrial Chain Analysis
Table Raw Materials Sources of Anti Obesity Drugs Major Manufacturers in 2015
Table Major Buyers of Anti Obesity Drugs
Table Distributors/Traders List
Figure China Anti Obesity Drugs Capacity, Production and Growth Rate Forecast (2016-2021)
Figure China Anti Obesity Drugs Revenue and Growth Rate Forecast (2016-2021)
Table China Anti Obesity Drugs Production, Import, Export and Consumption Forecast (2016-2021)
Table China Anti Obesity Drugs Production Forecast by Type (2016-2021)
Table China Anti Obesity Drugs Consumption Forecast by Application (2016-2021)